Improving CT prediction of treatment response in patients with metastatic colorectal carcinoma using statistical learning theory
暂无分享,去创建一个
Dan Margolis | Elizabeth A Krupinski | Ronald Gottlieb | Jack Y. Yang | E. Krupinski | W. Land | D. Margolis | Jack Y Yang | Walker H Land | R. Gottlieb
[1] L. Lesko,et al. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. , 2001, Annual review of pharmacology and toxicology.
[2] S. Larson,et al. The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development , 2005, Clinical Cancer Research.
[3] James H Thrall,et al. Biomarkers in imaging: realizing radiology's future. , 2003, Radiology.
[4] Nello Cristianini,et al. Kernel Methods for Pattern Analysis , 2003, ICTAI.
[5] Daniel C Sullivan,et al. Functional imaging in lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] R. F. Wagner,et al. Assessment methodologies and statistical issues for computer-aided diagnosis of lung nodules in computed tomography: contemporary research topics relevant to the lung image database consortium. , 2004, Academic radiology.
[7] A. Miller,et al. Reporting results of cancer treatment , 1981, Cancer.
[8] N. Obuchowski. How many observers are needed in clinical studies of medical imaging? , 2004, AJR. American journal of roentgenology.
[9] A. Satterfield,et al. TREATMENT , 1924, California and western medicine.
[10] R. Brereton,et al. Support vector machines for classification and regression. , 2010, The Analyst.
[11] M. Okada,et al. [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]. , 2009, Gan to kagaku ryoho. Cancer & chemotherapy.
[12] E. Boyko,et al. The use of risk factors in medical diagnosis: opportunities and cautions. , 1990, Journal of clinical epidemiology.
[13] A. Padhani,et al. The RECIST criteria: implications for diagnostic radiologists , 2001 .
[14] L. Schwartz,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.
[15] May,et al. [Wiley Series in Probability and Statistics] Applied Survival Analysis (Regression Modeling of Time-to-Event Data) || Extensions of the Proportional Hazards Model , 2008 .
[16] Wafik S El-Deiry,et al. Imaging and oncologic drug development. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] W. Heindel,et al. Volumetric measurements of pulmonary nodules at multi-row detector CT: in vivo reproducibility , 2003, European Radiology.
[18] R. D. Hunter,et al. WHO Handbook for Reporting Results of Cancer Treatment , 1980 .
[19] V. Goh,et al. Quantitative assessment of tissue perfusion using MDCT: comparison of colorectal cancer and skeletal muscle measurement reproducibility. , 2006, AJR. American journal of roentgenology.
[20] L. Schwartz,et al. Lung cancer: computerized quantification of tumor response--initial results. , 2006, Radiology.
[21] Jack Y. Yang,et al. New statistical learning theory paradigms adapted to breast cancer diagnosis/classification using image and non-image clinical data , 2008, Int. J. Funct. Informatics Pers. Medicine.
[22] M. Pepe,et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. , 2004, American journal of epidemiology.
[23] Richard Pazdur,et al. End points and United States Food and Drug Administration approval of oncology drugs. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] T E Walsh,et al. Reporting results. , 1969, Archives of otolaryngology.
[25] E. Halpern,et al. CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. , 2002, Radiology.
[26] Mark J. Ratain,et al. Measuring response in a post-RECIST world: from black and white to shades of grey , 2006, Nature Reviews Cancer.
[27] G. Chatellier,et al. Pulmonary nodules: preliminary experience with three-dimensional evaluation. , 2004, Radiology.
[28] Rabiya S Tuma,et al. Sometimes size doesn't matter: reevaluating RECIST and tumor response rate endpoints. , 2006, Journal of the National Cancer Institute.
[29] R. Munden,et al. Imaging of the patient with non-small cell lung cancer. , 2005, Radiology.
[30] L. Schwartz,et al. Imaging response assessment in oncology , 2006, Cancer imaging : the official publication of the International Cancer Imaging Society.
[31] S Saini,et al. Tumour size measurement in an oncology clinical trial: comparison between off-site and on-site measurements. , 2003, Clinical radiology.
[32] J E Husband,et al. Evaluation of the response to treatment of solid tumours – a consensus statement of the International Cancer Imaging Society , 2004, British Journal of Cancer.
[33] M. Christian,et al. [New guidelines to evaluate the response to treatment in solid tumors]. , 2000, Bulletin du cancer.
[34] James H Thrall,et al. Using imaging biomarkers to accelerate drug development and clinical trials. , 2005, Drug discovery today.
[35] C. Jaffe. Measures of response: RECIST, WHO, and new alternatives. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] M. Rosen,et al. Primer on imaging technologies for cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Bruce D Cheson,et al. Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development , 2005, Clinical Cancer Research.
[38] P. Therasse. Erratum to ''Measuring the clinical response. What does it mean?'' (European Journal of Cancer, 38 (2002) 1817-1823) § , 2003 .
[39] Nello Cristianini,et al. An Introduction to Support Vector Machines and Other Kernel-based Learning Methods , 2000 .
[40] M. Christian,et al. Measuring response in solid tumors: unidimensional versus bidimensional measurement. , 1999, Journal of the National Cancer Institute.
[41] Dansheng Song,et al. A kernelised fuzzy-Support Vector Machine CAD system for the diagnosis of lung cancer from tissue images , 2008, Int. J. Funct. Informatics Pers. Medicine.
[42] Curtis P Langlotz,et al. Automatic structuring of radiology reports: harbinger of a second information revolution in radiology. , 2002, Radiology.
[43] Elizabeth A. Krupinski,et al. Improving CT prediction of treatment response in patients with metastatic colorectal carcinoma using statistical learning , 2010, Int. J. Comput. Biol. Drug Des..
[44] P. Therasse. Measuring the clinical response. What does it mean? , 2001, European journal of cancer.
[45] L. Washington,et al. Inherent variability of CT lung nodule measurements in vivo using semiautomated volumetric measurements. , 2006, AJR. American journal of roentgenology.